Prescription drug · NDA
Ohtuvayre (Ensifentrine) NDC 83034-003
Ensifentrine 3 mg/2.5mL · Suspension · Respiratory (Inhalation) · MERCK SHARP & DOHME LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 83034-003-60 | 83034000360 | 60 POUCH in 1 CARTON (83034-003-60) / 1 AMPULE in 1 POUCH (83034-003-01) / 2.5 mL in 1 AMPULEMarketed from Jun 26, 2024 | |
| 83034-003-65 | 83034000365 | 60 POUCH in 1 CARTON (83034-003-65) / 5 AMPULE in 1 POUCH (83034-003-05) / 2.5 mL in 1 AMPULEMarketed from Jun 26, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ohtuvayre
- Generic name (nonproprietary)
- ensifentrine
- Active ingredients
- Ensifentrine — 3 mg/2.5mL
- Dosage form
- Suspension
- Route
- Respiratory (Inhalation)
- Labeler
- MERCK SHARP & DOHME LLCNDC labeler code 83034
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 217389
- Marketing start
- Listing expires
- Other FDA classes
- Phosphodiesterase 3 Inhibitors (Mechanism)Phosphodiesterase 4 Inhibitors (Mechanism)
- Identifiers
- Product ID 83034-003_6806e1d0-c260-427f-b661-044ca81de168SPL ID 6806e1d0-c260-427f-b661-044ca81de168SPL set ID e6433c98-41a0-4f99-8f7f-d0e9db6e3f40RxCUI 2687221, 2687226UNII 3E3D8T1GIX
- Pharmacologic class
- Phosphodiesterase 3 Inhibitor; Phosphodiesterase 4 Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N483034000360followed by a unit qualifier and the quantityPackage 83034-0003-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
OHTUVAYRE is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients. OHTUVAYRE is a phosphodiesterase 3 (PDE3) inhibitor and phosphodiesterase 4 (PDE4) inhibitor indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 83034-003
- What is NDC 83034-003?
- 83034-003 is the product NDC for Ohtuvayre (ensifentrine), Ensifentrine 3 mg/2.5mL suspension, listed with the FDA by MERCK SHARP & DOHME LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Ohtuvayre (Ensifentrine).
- What is the active ingredient?
- Ensifentrine.
- Who is the labeler?
- MERCK SHARP & DOHME LLC, NDC labeler code 83034. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Ohtuvayre?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.